47°32'N 8°13'E

Park Innovaare

Switzerland Innovation Park innovaare

Located in close proximity to the Paul Scherrer Institute (PSI) and its unique complex of large-scale research facilities, Switzerland Innovation Park innovaare and the companies based there profit from the extensive collaboration opportunities with leading experts in four innovation focus areas: accelerator technology, advanced materials and processes, human health, and energy. The outstanding conditions offered by the Canton of Aargau make Switzerland Innovation Park innovaare an excellent choice for innovative and research-oriented companies.

Profile

Switzerland Innovation Park innovaare is an innovation center situated in close proximity to the Paul Scherrer Institute (PSI) and its large-scale research facilities. Here, driven by the PSI’s expertise, innovations in the fields of accelerator technology, advanced materials and processes, human health, and energy are transformed into marketable ideas.

The purpose of Switzerland Innovation Park innovaare is to develop and offer the Organizing Institution and companies relocating to the park an exceptional, focused support program, to continuously adapt the program to the needs of those companies, and to market requirements, with the aim of quickly transforming investments and technologies into marketable innovations.

The companies located at Switzerland Innovation Park innovaare benefit from access to the PSI’s large-scale research facilities and the opportunity to collaborate with a number of highly qualified specialists, researchers, and engineers as well as an international network of institutes, universities, development partners, and knowledge transfer platforms based nearby. 

Located in Villigen in the Canton of Aargau, in close proximity to the Paul Scherrer Institute (PSI) and its large-scale research facilities, Switzerland Innovation Park innovaare benefits from a scientifically rich and economically prosperous environment. Innovators from the fields of fundamental research and industrial research and development profit greatly from the advantages offered by this location; as an industrial center, the Canton is home to a number of innovation-driven industrial companies and provides the ideal breeding ground for the transfer of technology.

Park innovAARE – Profil

Site

The large-scale research facilities of Switzerland’s largest scientific and engineering research center provide the inspiration for Switzerland Innovation Park innovaare’s research focus areas. Driven by leading expertise in accelerator technology, Switzerland Innovation Park innovaare concentrates on innovations in the following four fields: accelerator technology, advanced materials and processes, human health, and energy. Each of these fields is involved in the development of a broad range of innovations that benefit society, in areas such as renewable energy, nanotechnology, materials research, and cancer treatments.

Park innovAARE – Lage

Research and innovation focus areas

The large-scale research facilities of Switzerland’s largest scientific and engineering research center provide the inspiration for Switzerland Innovation Park innovaare’s research focus areas.

4 Innovation Areas

Accelerator technology

Accelerator technology

More

The key competences of the Paul Scherrer Institute (PSI) are the design, construction, and running of accelerator-based large-scale research facilities and the development of associated technologies and processes. This expertise puts the PSI at the international forefront of their field.

Advanced materials and processes

Advanced materials and processes

More

The basis and common denominator for many technologies and their industrial applications is materials science, which explores how the interior structure and observable properties of different materials are connected. It provides important foundations for the development of new materials and applications.

Energy

Energy

More

If we want to use renewable energies successfully in future, the integration of the existing energy systems is a key challenge. Energy suppliers, network operators, technology companies, large-scale consumers, and research have to work together to seek innovative and sustainable strategies and solutions.

Human health

Human health

More

In the field of human health, research is conducted on basic questions of structural biology, cancer therapy, and integrated optical measurement systems for medical X-ray diagnostics and pharmaceutical analytics. The decoding of protein structures with a view to developing new drugs is important in structural biology. The focus here is on proton beam cancer therapy and developing modern radiopharmaceuticals and tracers for the diagnosis and treatment of tumors.

    Featured Residents

    Switzerland Innovation Park innovaare offers an outstanding location with excellent facilities and a focused support program for technology- and research-driven companies. 
    The following companies have already taken up this offer:

    Advanced Accelerator Technologies AG

    Advanced Accelerator Technologies AG (AAT) was founded in 2015 as a joint initiative between the Paul Scherrer Institute (PSI) and a range of industry partners, some of which are international. The main aim of AAT is to commercialize the PSI’s leading know-how concerning accelerators, experimentation, and large-scale facilities, as well as the institute’s outstanding application expertise regarding particle beams and photons in the areas of science, research, and industrial processes.

    nomoko AG

    nomoko AG has developed a new technology to produce cost-effective and compact extremely high-resolution cameras. It is aiming to develop an 800-megapixel camera that is smaller than a conventional digital single-lens reflex camera. Thanks to their superlative resolution, the resulting images have an extremely high level of detail and information density, rendering them ideal for use in robotics or simulations.

    leadXpro AG

    leadXpro AG specializes in the development and optimization of pharmaceutical active substances. The company applies research from the Paul Scherrer Institute (PSI) in the field of membrane proteins, as well as world-leading technologies to investigate protein structures. Further, the new large-scale research facility at the PSI, the SwissFEL (currently under construction), offers excellent potential for this close collaboration.